%0 Journal Article
%T Omalizumab and long-term quality of life outcomes in patients with
moderate-to-severe allergic asthma: a systematic review
%A Chiara Martinotti
%A Claudia Pitotti
%A Francesco Menzella
%A Giacomo Matteo Bruno
%A Giorgio Lorenzo Colombo
%A Maria Chiara Valentino
%A Martina Oselin
%A Sergio Di Matteo
%J Archive of "Therapeutic Advances in Respiratory Disease".
%D 2019
%R 10.1177/1753466619841350
%X Asthma is a highly prevalent chronic inflammatory airways disease, with a considerable impact on quality of life (QoL). To express the effects of asthma on patients¡¯ subjective experience, patient-reported outcomes (PROs) represent an important instrument. The asthma QoL questionnaire (AQLQ) is one of the main PROs among these
%K Ashtma
%K quality of life
%K review
%K omalizumab
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492364/